JohnKHynesMD
Cardiology • Bellevue, WAAdult Congenital Heart Disease, Cardiac Electrophysiology
Physician
Are you Dr. Hynes?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1414 116th Ave Ne
Suite E
Bellevue, WA 98004Phone+1 425-455-9555Fax+1 425-454-2044
Summary
- Dr. John Hynes, MD is a cardiologist in Bellevue, Washington. He is currently licensed to practice medicine in Washington and Minnesota. He is affiliated with Overlake Medical Center and Clinics.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1979 - 1982- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1976 - 1979
University of Washington School of MedicineClass of 1976
Certifications & Licensure
WA State Medical License 1981 - 2020
MN State Medical License 1977 - 1981
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 14 citationsThe discovery of (R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl) thiazole-5-carboxamide (BMS-640994)-A potent and efficacious p38alpha MAP kinase inhibitor.John Hynes, Hong Wu, Sidney Pitt, Ding Ren Shen, Rosemary Zhang
Bioorganic & Medicinal Chemistry Letters. 2008-03-15 - 45 citationsDesign, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.John Hynes, Alaric J. Dyckman, Shuqun Lin, Stephen T. Wrobleski, Hong Wu
Journal of Medicinal Chemistry. 2008-01-10 - 20 citationsA review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation.Gerald V. Naccarelli, Deborah L. Wolbrette, Luna Bhatta, Mazhar Khan, John Hynes
Journal of Interventional Cardiac Electrophysiology. 2003-10-01
Professional Memberships
- Member
